These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series. Rishi P; Rishi E; Kuniyal L; Mathur G Oman J Ophthalmol; 2012 May; 5(2):79-82. PubMed ID: 22993460 [TBL] [Abstract][Full Text] [Related]
3. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report. Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187 [TBL] [Abstract][Full Text] [Related]
4. Radiation Macular Edema after Ru-106 Plaque Brachytherapy for Choroidal Melanoma Resolved by an Intravitreal Dexamethasone 0.7-mg Implant. Russo A; Avitabile T; Uva M; Faro S; Franco L; Sanfilippo M; Gulisano S; Toro M; De Grande V; Rametta S; Foti L; Longo A; Reibaldi M Case Rep Ophthalmol; 2012 Jan; 3(1):71-6. PubMed ID: 22529805 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors. Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480 [TBL] [Abstract][Full Text] [Related]
6. The Structural and Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Anti-VEGF Injection in Branched Retinal Vein Occlusion Patients by Optical Coherence Tomography Angiography Images Quantitation. Park JH; Kim EC Semin Ophthalmol; 2021 Oct; 36(7):475-481. PubMed ID: 33843438 [No Abstract] [Full Text] [Related]
7. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital]. Bernard Y; Bonnin N; Farguette F; Chiambaretta F J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial. Mishra SK; Sinha S; Chauhan R; Kumar A Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema. Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940 [TBL] [Abstract][Full Text] [Related]
20. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion. Bakri SJ; Omar AF J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]